Christopher K. Snider, MPH
Articles
June 9th 2023
Economics of a Health System’s Direct-to-Consumer Telemedicine for Its Employees
Krisda H. Chaiyachati, MD, MPH, MSHP Christopher K. Snider, MPH Nandita Mitra, PhD Ann Marie Huffenberger, DBA, RN, NEA-BC Susan McGinley, MSN, CRNP Regina Bristow, BS C. William Hanson III, MD Gregory Kruse, MSc, MPH Shivan J. Mehta, MD, MBA, MSHP David A. Asch, MD, MBA
A direct-to-consumer telemedicine service resulted in lower per-episode unit costs for care within 7 days and only marginally increased the use of services overall.
November 17th 2021
An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19
Austin S. Kilaru, MD Stefanie B. Porges, MD Lindsay Grossman, BA M. Kit Delgado, MD Anna U. Morgan, MD Krisda H. Chaiyachati, MD David A. Asch, MD S. Ryan Greysen, MD Amy C. Lockwood, DNP Keith C. Hemmert, MD Susan McGinley, CRNP Nancy Mannion, DNP Ann Marie Huffenberger, DBA Eric Bressman, MD Nina O’Connor, MD Neda Khan, MHCI Mohan Balachandran, MS Christopher K. Snider, MPH Aria Xiong, MS Nandita Mitra, PhD Kathleen C. Lee, MD
For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
